Jay David Caplan - 06 Feb 2024 Form 4 Insider Report for Fractyl Health, Inc. (GUTS)

Role
President, Chief Product Off.
Signature
/s/ Lisa A. Davidson, Attorney-in-fact
Issuer symbol
GUTS
Transactions as of
06 Feb 2024
Net transactions value
$0
Form type
4
Filing time
08 Feb 2024, 16:37:24 UTC
Previous filing
01 Feb 2024
Next filing
13 Sep 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GUTS Common Stock Conversion of derivative security +23,299 +6.9% 358,806 06 Feb 2024 By Trust F1, F2
transaction GUTS Common Stock Conversion of derivative security +118,810 118,810 06 Feb 2024 By Family Trust F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GUTS Series A Preferred Stock Conversion of derivative security -50,000 -100% 0 06 Feb 2024 Common Stock 23,299 By Trust F1, F2
transaction GUTS Series B Preferred Stock Conversion of derivative security -177,726 -100% 0 06 Feb 2024 Common Stock 82,817 By Family Trust F1
transaction GUTS Series C-1 Preferred Stock Conversion of derivative security -44,730 -100% 0 06 Feb 2024 Common Stock 20,843 By Family Trust F1
transaction GUTS Series C-2 Preferred Stock Conversion of derivative security -32,514 -100% 0 06 Feb 2024 Common Stock 15,150 By Family Trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock.
F2 The Reporting Person's Form 3 filed on February 1, 2024 inadvertently omitted the securities held by the Jay D. Caplan 2021 Irrevocable Trust.